From Name:
From Email:
To Name:
To Email:

Optional Message:


Report: Life sciences M&A and the rise of personalized medicine

from HIT Consultant

As the life sciences M&A reaches new heights, there seems to be no end in sight for life sciences companies’ hunger for acquisitions. Ninety-four percent of life sciences companies are planning to make an acquisition in the next year, with 91 percent of U.S. respondents expecting these to be cross-border transactions, according to a global study of 100 senior executives at life sciences companies by global law firm Reed Smith, commissioned by Mergermarket. more


Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063